Molecular pathology of the fibroblast growth factor family

Human Mutation

Volumn 30, Issue 9, 2009, Pages 1245-1255

  Krejci, Pavel ^a,b,c   Prochazkova, Jirina ^a,b   Bryja, Vitezslav ^a,b   Kozubik, Alois ^a,b   Wilcox, William R ^c,d  

^a MASARYK UNIVERSITY   (Czech Republic)

^b INSTITUTE OF BIOPHYSICS   (Czech Republic)

^c CEDARS SINAI MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Disease; FGF; Fibroblast growth factor; Genetics; Human; Mutation

Indexed keywords

CYTOKINE; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 10; FIBROBLAST GROWTH FACTOR 11; FIBROBLAST GROWTH FACTOR 12; FIBROBLAST GROWTH FACTOR 13; FIBROBLAST GROWTH FACTOR 14; FIBROBLAST GROWTH FACTOR 20; FIBROBLAST GROWTH FACTOR 23; FIBROBLAST GROWTH FACTOR 8; FIBROBLAST GROWTH FACTOR 9; FIBROBLAST GROWTH FACTOR RECEPTOR; HEPARAN SULFATE; UNCLASSIFIED DRUG;

ATAXIA; BLOOD VESSEL CALCIFICATION; BONE DYSPLASIA; CLEFT LIP; CLEFT PALATE; COGNITIVE DEFECT; COLORECTAL CARCINOMA; CRANIOFACIAL DYSPLASIA; CRANIOFACIAL MALFORMATION; DYSKINESIA; ENDOMETRIUM CARCINOMA; HEARING IMPAIRMENT; HUMAN; HYPERCALCEMIA; HYPOGONADOTROPIC HYPOGONADISM; HYPOPHOSPHATEMIA; HYPOPHOSPHATEMIC RICKETS; INNER EAR DISEASE; KALLMANN SYNDROME; KNOWLEDGE; LACRIMAL APLASIA; LACRIMATION DISORDER; MICHEL APLASIA; MICRODONTIA; MICROTIA; MULTIPLE MYELOMA; MUTATION; MYELOPROLIFERATIVE DISORDER; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOMALACIA; OVARY CARCINOMA; PARKINSON DISEASE; PATHOLOGY; PRIORITY JOURNAL; PROTEIN FAMILY; REGULATORY MECHANISM; REVIEW; SALIVARY GLAND APLASIA; SALIVARY GLAND DISEASE; SPINOCEREBELLAR DEGENERATION; TOOTH MALFORMATION; TUMOR CALCINOSIS;

ABNORMALITIES, MULTIPLE; CARCINOMA; CLEFT LIP; FIBROBLAST GROWTH FACTORS; HUMANS; HYPOGONADISM; MUTATION;

EID: 69549120039     PISSN: 10597794     EISSN: None     Source Type: Journal    
DOI: 10.1002/humu.21067     Document Type: Review

References (155)

1. Abdel-Rahman WM, Kalinina J, Shoman S, Eissa S, Ollikainen M, Elomaa O, Eliseenkova AV, Bützow R, Mohammadi M, Peltomäki P. 2008. Somatic FGF9 mutations in colorectal and endometrial carcinomas associated with membranous b-catenin. Hum Mutat 29:390-397.
2. Abu-Issa R, Smyth G, Smoak I, Yamamura K, Meyers EN. 2002. Fgf8 is required for pharyngeal arch and cardiovascular development in the mouse. Development 129:4613-4625. (Pubitemid 35203742)
3. ADHR Consortium. 2000. Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat Genet 26:345-348.
4. Allen BL, Filla MS, Rapraeger AC. 2001. Role of heparan sulfate as a tissue-specific regulator of FGF-4 and FGF receptor recognition. J Cell Biol 155:845-858.
5. Alsmadi O, Meyer BF, Alkuraya F, Wakil S, Alkayal F, Al-Saud H, Ramzan K, Al-Sayed M. 2009. Syndromic congenital sensorineural deafness, microtia and microdontia resulting from a novel homoallelic mutation in fibroblast growth factor 3 (FGF3). Eur J Hum Genet 17:14-21.
6. Alvarez Y, Alonso MT, Vendrell V, Zelarayan LC, Chamero P, Theil T, Bösl MR, Kato S, Maconochie M, Riethmacher D, Schimmang T. 2003. Requirements for FGF3 and FGF10 during inner ear formation. Development 130:6329-6338. (Pubitemid 38008830)
7. Antoine M, Reimers K, Dickson C, Kiefer P. 1997. Fibroblast growth factor 3, a protein with dual subcellular localization, is targeted to the nucleus and nucleolus by the concerted action of two nuclear localization signals and a nucleolar retention signal. J Biol Chem 272:29475-29481. (Pubitemid 27508032)
8. Araya K, Fukumoto S, Backenroth R, Takeuchi Y, Nakayama K, Ito N, Yoshii N, Yamazaki Y, Yamashita T, Silver J, Igarashi T, Fujita T. 2005. A novel mutation in fibroblast growth factor 23 gene as a cause of tumoral calcinosis. J Clin Endocrinol Metab 90:5523-5527. (Pubitemid 41415453)
9. Bai XY, Miao D, Goltzman D, Karaplis AC. 2003. The autosomal dominant hypophosphatemic rickets R176Q mutation in fibroblast growth factor 23 resists proteolytic cleavage and enhances in vivo biological potency. J Biol Chem 278:9843-9849. (Pubitemid 36800487)
10. Bai X, Miao D, Li J, Goltzman D, Karaplis AC. 2004. Transgenic mice overexpressing human fibroblast growth factor 23 (R176Q) delineate a putative role for parathyroid hormone in renal phosphate wasting disorders. Endocrinology 145:5269-5279. (Pubitemid 39551149)
11. Bellot F, Crumley G, Kaplow JM, Schlessinger J, Jaye M, Dionne CA. 1991. Ligandinduced transphosphorylation between different FGF receptors. EMBO J 10:2849-2854. (Pubitemid 21905302)
12. Benet-Pagès A, Orlik P, Strom TM, Lorenz-Depiereux B. 2005. An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia. Hum Mol Genet 14:385-390. (Pubitemid 40220655)
13. Brusse E, de Koning I, Maat-Kievit A, Oostra BA, Heutink P, van Swieten JC. 2006. Spinocerebellar ataxia associated with a mutation in the fibroblast growth factor 14 gene (SCA27): a new phenotype. Mov Disord 21:396-401.
14. Cai Q, Hodgson SF, Kao PC, Lennon VA, Klee GG, Zinsmiester AR, Kumar R. 1994. Brief report: inhibition of renal phosphate transport by a tumor product in a patient with oncogenic osteomalacia. N Engl J Med 330:1645-1649. (Pubitemid 24166865)
15. Chartier-Harlin MC, Kachergus J, Roumier C, Mouroux V, Douay X, Lincoln S, Levecque C, Larvor L, Andrieux J, Hulihan M, Waucquier N, Defebvre L, Amouyel P, Farrer M, Destée A. 2004. Alpha-synuclein locus duplication as a cause of familiar Parkinson's disease. Lancet 364:1169-1171. (Pubitemid 39296604)
16. Chefetz I, Heller R, Galli-Tsinopoulou A, Richard G, Wollnik B, Indelman M, Koerber F, Topaz O, Bergman R, Sprecher E, Schoenau E. 2005. A novel homozygous missense mutation in FGF23 causes familial tumoral calcinosis associated with disseminated visceral calcification. Hum Genet 118:261-266. (Pubitemid 41672088)
17. Cholfin JA, Rubenstein JLR. 2007. Patterning of frontal cortex subdivisions by Fgf17. Proc Natl Acad Sci USA 104:7652-7657.
18. Cormier S, Leroy C, Delezoide AL, Silve C. 2005. Expression of fibroblast growth factors 18 and 23 during human embryonic and fetal development. Gene Expr Patterns 5:569-573. (Pubitemid 40331399)
19. Dalski A, Atici J, Kreuz FR, Hellenbroich Y, Schwinger E, Zühlke C. 2005. Mutation analysis in the fibroblast growth factor 14 gene: frameshift mutation and polymorphisms in patients with inherited ataxias. Eur J Hum Genet 13:118-120.
20. de Lau LML, Breteler MMB. 2006. Epidemiology of Parkinson's disease. Lancet Neurol 5:525-535.
21. De Moerlooze L, Spencer-Dene B, Revest JM, Hajihosseini M, Rosewell I, Dickson C. 2000. An important role for the IIIb isoform of fibroblast growth factor receptor 2 (FGFR2) in mesenchymal-epithelial signalling during mouse organogenesis. Development 127:483-492. (Pubitemid 30093396)
22. Delli-Bovi P, Curatola AM, Newman KM, Sato Y, Moscatelli D, Hewick RM, Rifkin DB, Basilico C. 1988. Processing, secretion, and biological properties of a novel growth factor of the fibroblast growth factor family with oncogenic potential. Mol Cell Biol 8:2933-2941. (Pubitemid 18165076)
23. Deng C, Wynshaw-Boris A, Zhou F, Kuo A, Leder P. 1996. Fibroblast growth factor receptor 3 is a negative regulator of bone growth. Cell 84:911-921. (Pubitemid 26106860)
24. Dickson C, Smith R, Brookes S, Peters G. 1984. Tumorigenesis by mouse mammary tumor virus: proviral activation of a cellular gene in the common integration region int-2. Cell 37:529-536. (Pubitemid 14079047)
25. Dodé C, Levilliers J, Dupont JM, De Paepe A, Le Dû N, Soussi-Yanicostas N, Coimbra RS, Delmaghani S, Compain-Nouaille S, Baverel F, Pêcheux C, Le Tessier D, Cruaud C, Delpech M, Speleman F, Vermeulen S, Amalfitano A, Bachelot Y, Bouchard P, Cabrol S, Carel JC, Delemarre-van de Waal H, Goulet- Salmon B, Kottler ML, Richard O, Sanchez-Franco F, Saura R, Young J, Petit C, Hardelin JP. 2003. Loss-of-function mutations in FGFR1 cause autosomal dominant Kallmann syndrome. Nat Genet 33:463-465. (Pubitemid 36390006)
26. Drücke TB, Prié D. 2007. Klotho spins the thread of life - what does Klotho do to the receptors of fibroblast growth factor-23 (FGF23)? Nephrol Dial Transplant 22:1524-1526. (Pubitemid 47073749)
27. Dudas M, Li WY, Kim J, Yang A, Kaartinen V. 2007. Palatal fusion - where do the midline cells go? A review on cleft palate, a major human birth defect. Acta Histochem 109:1-14. (Pubitemid 46188337)
28. Econs MJ, McEnery PT. 1997. Autosomal dominant hypophosphataemic rickets/osteomalacia: clinical characterisation of a novel renal-phosphate wasting disorder. J Clin Endocrinol Metab 82:674-681.
29. El-Hariry I, Pignatelli M, Lemoine NR. 2001. FGF-1 and FGF-2 modulate the E-cadherin/catenin system in pancreatic adenocarcinoma cell lines. Br J Cancer 84:1656-1663. (Pubitemid 32612498)
30. Entesarian M, Matsson H, Klar J, Bergendal B, Olson L, Arakaki R, Hayashi Y, Ohuchi H, Falahat B, Bolstad AI, Jonsson R, Wahren-Herlenius M, Dahl N. 2005. Mutations in the gene encoding fibroblast growth factor 10 are associated with aplasia of lacrimal and salivary glands. Nat Genet 37:125-127.
31. Entesarian M, Dahlqvist J, Shashi V, Stanley CS, Falahat B, Reardon W, Dahl N. 2007. FGF10 missense mutations in aplasia of lacrimal and salivary glands (ALSG). Eur J Hum Genet 15:379-382. (Pubitemid 46306536)
32. Falardeau J, Chung WCJ, Beenken A, Raivio T, Plummer L, Sidis Y, Jacobson- Dickman EE, Eliseenkova AV, Ma J, Dwyer A, Quinton R, Na S, Hall JE, Huot C, Alois N, Pearce SH, Cole LW, Hughes V, Mohammadi M, Tsai P, Pitteloud N. 2008. Decreased FGF8 signaling causes deficiency of gonadotropin-releasing hormone in humans and mice. J Clin Invest 118:2822-2831.
33. Fechner A, Fong S, McGovern P. 2008. A review of Kallmann syndrome: genetics, pathophysiology, and clinical management. Obstet Gynecol Surv 63:189-194. (Pubitemid 351612437)
34. Ferguson MW. 1988. Palate development: fibroblast growth factor 1 (FGF1) does not account for the mild phenotypic defects. Development 103(Suppl):41-60.
35. Francannet C, Vanlieferinghen P, Dechelotte P, Urbain MF, Campagne D, Malpuech G. 1994. LADD syndrome in five members of a three-generation family and prenatal diagnosis. Genet Couns 5:85-91. (Pubitemid 24096824)
36. Frishberg Y, Ito N, Rinat C, Yamazaki Y, Feinstein S, Urakawa I, Navon-Elkan P, Becker-Cohen R, Yamashita T, Araya K, Igarashi T, Fujita T, Fukumoto S. 2007. Hyperostosis-hyperphosphatemia syndrome: a congenital disorder of O-glycosylation associated with augmented processing of fibroblast growth factor 23. J Bone Miner Res 22:235-242. (Pubitemid 46167794)
37. Fukumoto S, Yamashita T. 2007. FGF23 is a hormone-regulating phosphate metabolism - unique biological characteristics of FGF23. Bone 40:1190-1195. (Pubitemid 46550981)
38. Garringer HJ, Malekpour M, Esteghamat F, Mortazavi SM, Davis SI, Farrow EG, Yu X, Arking DE, Dietz HC, White KE. 2008. Molecular genetic and biochemical analyses of FGF23 mutations in familial tumoral calcinosis. Am J Physiol Endocrinol Metab 295:E929-E937.
39. Goetz R, Beenken A, Ibrahimi OA, Kalinina J, Olsen SK, Eliseenkova AV, Xu C, Neubert TA, Zhang F, Linhardt RJ, Yu X, White KE, Inagaki T, Kliewer SA, Yamamoto M, Kurosu H, Ogawa Y, Kuro-o M, Lanske B, Razzaque MS, Mohammadi M. 2007. Molecular insights into the Klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members. Mol Cell Biol 27:3417-3428. (Pubitemid 46685217)
40. Goldfarb M. 2005. Fibroblast growth factor homologous factors: evolution, structure, and function. Cytokine Growth Factor Rev 16:215-220. (Pubitemid 40616118)
41. Goldfarb M, Schoorlemmer J, Williams A, Diwakar S, Wang Q, Huang X, Giza J, Tchetchik D, Kelley K, Vega A, Matthews G, Rossi P, Ornitz DM, D'Angelo E. 2007. Fibroblast growth factor homologous factors control neuronal excitability through modulation of voltage-gated sodium channels. Neuron 55:449-463. (Pubitemid 47126267)
42. Govindarajan V, Ito M, Makarenkova HP, Lang RA, Overbeek PA. 2000. Endogenous and ectopic gland induction by FGF-10. Dev Biol 225:188-200. (Pubitemid 30679992)
43. Grose R, Dickson C. 2005. Fibroblast growth factor signaling in tumorigenesis. Cytokine Growth Factor Rev 16:179-186. (Pubitemid 40616115)
44. Guimond S, Maccarana M, Olwin BB, Lindahl U, Rapraeger AC. 1993. Activating and inhibitory heparin sequences for FGF-2 (basic FGF). Distinct requirements for FGF-1, FGF-2, and FGF-4. J Biol Chem 268:23906-23914. (Pubitemid 23335365)
45. Hadari YR, Gotoh N, Kouhara H, Lax I, Schlessinger J. 2001. Critical role for the docking-protein FRS2 alpha in FGF receptor-mediated signal transduction pathways. Proc Natl Acad Sci USA 98:8578-8583. (Pubitemid 32678070)
46. Hart KC, Robertson SC, Kanemitsu MY, Meyer AN, Tynan JA, Donoghue DJ. 2000. Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4. Oncogene 19:3309-3320.
47. Hatch EP, Noyes CA, Wang X, Wright TJ, Mansour SL. 2007. Fgf3 is required for dorsal patterning and morphogenesis of the inner ear epithelium. Development 134:3615-3625. (Pubitemid 350104372)
48. Hendrix ND, Wu R, Kuick R, Schwartz DR, Fearon ER, Cho KR. 2006. Fibroblast growth factor 9 has oncogenic activity and is a downstream target of Wnt signaling in ovarian endometrioid adenocarcinomas. Cancer Res 66:1354-1362. (Pubitemid 43259914)
49. Hollister DW, Klein SH, De Jager HJ, Lachman RS, Rimoin DL. 1973. The lacrimoauriculo- dento-digital syndrome. J Pediatr 83:438-444.
50. HYP Consortium. 1995. A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. Nat Genet 11:130-136.
51. Ichikawa S, Imel EA, Kreiter ML, Yu X, Mackenzie DS, Sorenson AH, Goetz R, Mohammadi M, White KE, Econs MJ. 2007. A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis. J Clin Invest 117:2684-2691. (Pubitemid 47494368)
52. Igarashi M, Finch PW, Aaronson SA. 1998. Characterization of recombinant human fibroblast growth factor (FGF)-10 reveals functional similarities with keratinocyte growth factor (FGF-7). J Biol Chem 273:13230-13235. (Pubitemid 28246895)
53. Inoue Y, Segawa H, Kaneko I, Yamanaka S, Kusano K, Kawakami E, Furutani J, Ito M, Kuwahata M, Saito H, Fukushima N, Kato S, Kanayama HO, Miyamoto K. 2005. Role of the vitamin D receptor in FGF23 action on phosphate metabolism. Biochem J 390:325-331. (Pubitemid 41192259)
54. Itoh N. 2007. The fgf families in humans, mice, and zebrafish: their evolutional processes and roles in development, metabolism, and disease. Biol Pharm Biol 30:1819-1825. (Pubitemid 47607758)
55. Jaskoll T, Abichaker G, Witcher D, Sala FG, Bellusci S, Hajihosseini MK, Melnick M. 2005. FGF10/FGFR2b signaling plays essential roles during in vivo embryonic submandibular salivary gland morphogenesis. BMC Dev Biol 5:11-22. (Pubitemid 41185300)
56. Jugessur A, Murray JC. 2005. Orofacial clefting: recent insights into a complex trait. Curr Opin Genet Dev 15:270-278. (Pubitemid 40726050)
57. Kato K, Jeanneau C, Tarp MA, Benet-Pagès A, Lorenz-Depiereux B, Bennett EP, Mandel U, Strom TM, Clausen H. 2006. Polypeptide GalNAc-transferase T3 and familial tumoral calcinosis. Secretion of fibroblast growth factor 23 requires O-glycosylation. J Biol Chem 281:18370-18377. (Pubitemid 44035494)
58. Kiefer P, Dickson C. 1995. Nucleolar association of fibroblast growth factor 3 via specific sequence motifs has inhibitory effects on cell growth. Mol Cell Biol 15:4364-4374.
59. Kirik D, Annet LE, Burger C, Muzyczka N, Mandel RJ, Bjorklund A. 2002. Nigrostriatal alpha-synocleiopathy induced by viral vector-mediated overexpression of human alpha-synuclein: a new primate model of Parkinson's disease. Proc Natl Acad Sci USA 100:2884-2889. (Pubitemid 36297593)
60. Klint P, Kanda S, Claesson-Welsh L. 1995. Shc and a novel 89-kDa component couple to the Grb2-Sos complex in fibroblast growth factor-2-stimulated cells. J Biol Chem 270:23337-23344.
61. Klint P, Claesson-Welsh L. 1999. Signal transduction by fibroblast growth factor receptors. Front Biosci 4:D165-D177.
62. Korah RM, Sysounthone V, Golowa Y, Wieder R. 2000. Basic fibroblast growth factor confers a less malignant phenotype in MDA-MB-231 human breast cancer cells. Cancer Res 60:733-740. (Pubitemid 30094575)
63. Krejci P, Dvorakova D, Krahulcova E, Pachernik J, Mayer J, Hampl A, Dvorak P. 2001. FGF-2 abnormalities in B cell chronic lymphocytic and chronic myeloid leukemias. Leukemia 15:228-237. (Pubitemid 32175454)
64. Krejci P, Bryja V, Pachernik J, Hampl A, Pogue R, Mekikian P, Wilcox WR. 2004. FGF2 inhibits proliferation and alters the cartilage-like phenotype of RCS cells. Exp Cell Res 297:152-164. (Pubitemid 38759570)
65. Krejci P, Krakow D, Mekikian PB, Wilcox WR. 2007a. Fibroblast growth factors 1, 2, 17, and 19 are the predominant FGF ligands expressed in human fetal growth plate cartilage. Pediatr Res 61:267-272. (Pubitemid 46303627)
66. Krejci P, Masri B, Salazar L, Farrington-Rock C, Prats H, Michels Thompson L, Wilcox WR. 2007b. Bisindolylmaleimide I suppresses fibroblast growth factor-mediated activation of Erk MAP kinase in chondrocytes by preventing Shp2 association with the Frs2 and Gab1 adaptor proteins. J Biol Chem 282:2929-2936. (Pubitemid 47084346)
67. Krejci P, Pejchalova K, Rosenbloom BE, Rosenfelt FP, Tran EL, Laurell H, Wilcox WR. 2007c. The antiapoptotic protein Api5 and its partner, high molecular weight FGF2, are up-regulated in B cell chronic lymphoid leukemia. J Leukoc Biol 82:1363-1364.
68. Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi H, Suga T, Utsugi T, Ohyama Y, Kurabayashi M, Kaname T, Kume E, Iwasaki H, Iida A, Shiraki-Iida T, Nishikawa S, Nagai R, Nabeshima YI. 1997. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 390:45-51. (Pubitemid 27494749)
69. Kurosu H, Ogawa Y, Miyoshi M, Yamamoto M, Nandi A, Rosenblatt KP, Baum MG, Schiavi S, Hu MC, Moe OW, Kuro-o M. 2006. Regulation of fibroblast growth factor-23 signaling by klotho. J Biol Chem 281:6120-6123. (Pubitemid 43847540)
70. Kusche-Gullberg M, Kjellén L. 2003. Sulfotransferases in glycosaminoglycan biosynthesis. Curr Opin Struct Biol 13:605-611.
71. Laezza F, Gerber BR, Lou JY, Kozel MA, Hartman H, Craig AM, Ornitz DM, Nerbonne JM. 2007. The FGF14(F145S) mutation disrupts the interaction of FGF14 with voltage-gated Na1channels and impairs neuronal excitability. J Neurosci 27:12033-12044. (Pubitemid 350072101)
72. Larsson T, Marsell R, Schipani E, Ohlsson C, Ljunggren O, Tenenhouse HS, Jüppner H, Jonsson KB. 2004. Transgenic mice expressing fibroblast growth factor 23 under the control of the alpha1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis. Endocrinology 145:3087-3094. (Pubitemid 38829975)
73. Larsson T, Yu X, Davis SI, Draman MS, Mooney SD, Cullen MJ, White KE. 2005. A novel recessive mutation in fibroblast growth factor-23 causes familial tumoral calcinosis. J Clin Endocrinol Metab 90:2424-2427. (Pubitemid 40586293)
74. Lew ED, Bae JH, Rohmann E, Wollnik B, Schlessinger J. 2007. Structural basis for reduced FGFR2 activity in LADD syndrome: implications for FGFR autoinhibition and activation. Proc Natl Acad Sci USA 104:19802-19807.
75. Lin X, Buff EM, Perrimon N, Michelson AM. 1999. Heparan sulfate proteoglycans are essential for FGF receptor signaling during Drosophila embryonic development. Development 126:3715-3723. (Pubitemid 29440471)
76. Liu CJ, Dib-Hajj SD, Waxman SG. 2001. Fibroblast growth factor homologous factor 1B binds to the C terminus of the tetrodotoxin-resistant sodium channel rNav1.9a (NaN). J Biol Chem 276:18925-18933. (Pubitemid 37411213)
77. Liu Z, Xu J, Colvin JS, Ornitz DM. 2002. Coordination of chondrogenesis and osteogenesis by fibroblast growth factor 18. Genes Dev 16:859-869. (Pubitemid 34280109)
78. Makarenkova HP, Ito M, Govindarajan V, Faber SC, Sun L, McMahon G, Overbeek PA, Lang RA. 2000. FGF10 is an inducer and Pax6 a competence factor for lacrimal gland development. Development 127:2563-2572. (Pubitemid 30426804)
79. Mansour SL, Goddard JM, Capecchi MR. 1993. Mice homozygous for a targeted disruption of the proto-oncogene int-2 have developmental defects in the tail and inner ear. Development 117:13-28. (Pubitemid 23094154)
80. Masi L, Gozzini A, Franchi A, Campanacci D, Amedei A, Falchetti A, Franceschelli F, Marcucci G, Tanini A, Capanna R, Brandi ML. 2009. A novel recessive mutation of fibroblast growth factor-23 in tumoral calcinosis. J Bone Joint Surg Am 91:1190-1198.
81. McLeskey SW, Ding IY, Lippman ME, Kern FG. 1994. MDA-MB-134 breast carcinoma cells overexpress fibroblast growth factor (FGF) receptors and are growth-inhibited by FGF ligands. Cancer Res 54:523-530. (Pubitemid 2022538)
82. Meyers EN, Lewandoski M, Martin GR. 1998. An Fgf8 mutant allelic series generated by Cre- and Flp-mediated recombination. Nat Genet 18:136-141. (Pubitemid 28082459)
83. Michel P. 1863. Mémoire sur les anomalies congénitales de l'oreille interne. (A report on congenital anomalies of the inner ear.) Gazette Méd de Strasbourg 23:55-58.
84. Miller DL, Ortega S, Bashayan O, Basch R, Basilico C. 2000. Compensation by fibroblast growth factor 1 (FGF1) does not account for the mild phenotypic defects observed in FGF2 null mice. Mol Cell Biol 20:2260-2268. (Pubitemid 30123841)
85. Milunsky JM, Zhao G, Maher TA, Milunsky A. 2005. Agenesis or hypoplasia of major salivary and lacrimal glands due to FGF10 mutations. American College of Medical Genetics Annual Meeting, Dallas, TX: A100.
86. Milunsky JM, Zhao G, Maher TA, Colby R, Everman DB. 2006. LADD syndrome is caused by FGF10 mutations. Clin Genet 69:349-354.
87. Min H, Danilenko DM, Scully SA, Bolon B, Ring BD, Tarpley JE, DeRose M, Simonet WS. 1998. Fgf-10 is required for both limb and lung development and exhibits striking functional similarity to Drosophila branchless. Genes Dev 12:3156-3161. (Pubitemid 28496260)
88. Mohammadi M, Dikic I, Sorokin A, Burgess WH, Jaye M, Schlessinger J. 1996. Identification of six novel autophosphorylation sites on fibroblast growth factor receptor 1 and elucidation of their importance in receptor activation and signal transduction. Mol Cell Biol 16:977-989. (Pubitemid 26061669)
89. Mohammadi M, Olsen SK, Goetz R. 2005. A protein canyon in the FGF-FGF receptor dimer selects from an à la carte menu of heparan sulfate motifs. Curr Opin Struct Biol 15:506-516. (Pubitemid 41393481)
90. Montero A, Okada Y, Tomita M, Ito M, Tsurukami H, Nakamura T, Doetschman T, Coffin JD, Hurley MM. 2000. Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation. J Clin Invest 105:1085-1093. (Pubitemid 30217693)
91. Munoz-Sanjuan I, Simandl BK, Fallon JF, Nathans J. 1999. Expression of chicken fibroblast growth factor homologous factor (FHF)-1 and of differentially spliced isoforms of FHF-2 during development and involvement of FHF-2 in chicken limb development. Development 126:409-421. (Pubitemid 29083977)
92. Murase S, McKay RD. 2006. A specific survival response in dopaminergic neurons at most risk in Parkinson's disease. J Neurosci 26:9750-9760. (Pubitemid 44427714)
93. Ohbayashi N, Shibayama M, Kurotaki Y, Imanishi M, Fujimori T, Itoh N, Takada S. 2002. FGF18 is required for normal cell proliferation and differentiation during osteogenesis and chondrogenesis. Genes Dev 16:870-879. (Pubitemid 34280110)
94. Ohmachi S, Watanabe Y, Mikami T, Kusu N, Ibi T, Akaike A, Itoh N. 2000. FGF-20, a novel neurotrophic factor, preferentially expressed in the substantia negra pars compacta of rat brain. Biochem Biophys Res Commun 277:355-360. (Pubitemid 30807475)
95. Ohuchi H, Hori Y, Yamasaki M, Harada H, Sekine K, Kato S, Itoh N. 2000. FGF10 acts as a major ligand for FGF receptor 2 IIIb in mouse multi-organ development. Biochem Biophys Res Commun 277:643-649. (Pubitemid 30819733)
96. Olsen SK, Garbi M, Zampieri N, Eliseenkova AV, Ornitz DM, Goldfarb M, Mohammadi M. 2003. Fibroblast growth factor (FGF) homologous factors share structural but not functional homology with FGFs. J Biol Chem 278:34226-34236. (Pubitemid 37553265)
97. Ong SH, Hadari YR, Gotoh N, Guy GR, Schlessinger J, Lax I. 2001. Stimulation of phosphatidylinositol 3-kinase by fibroblast growth factor receptors is mediated by coordinated recruitment of multiple docking proteins. Proc Natl Acad Sci USA 98:6074-6079. (Pubitemid 32488195)
98. Ornitz DM, Yayon A, Flanagan JG, Svahn CM, Levi E, Leder P. 1992. Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells. Mol Cell Biol 12:240-247.
99. Ornitz DM, Xu J, Colvin JS, McEwen DG, MacArthur CA, Coulier F, Gao G, Goldfarb M. 1996. Receptor specificity of the fibroblast growth factor family. J Biol Chem 271:15292-15297. (Pubitemid 26195013)
100. Palmer PE. 1966. Tumoural calcinosis. Br J Radiol 39:518-525.
101. Pauley S, Wright TJ, Pirvola U, Ornitz D, Beisel K, Fritzsch B. 2003. Expression and function of FGF10 in mammalian inner ear development. Dev Dyn 227:203-215. (Pubitemid 36666749)
102. Peters KG, Marie J, Wilson E, Ives HE, Escobedo J, Del Rosario M, Mirda D, Williams LT. 1992. Point mutation of an FGF receptor abolishes phosphatidylinositol turnover and Ca2+flux but not mitogenesis. Nature 358:678-681.
103. Pirvola U, Spencer-Dene B, Xing-Qun L, Kettunen P, Thesleff I, Fritzsch B, Dickson C, Ylikoski J. 2000. FGF/FGFR-2(IIIb) signaling is essential for inner ear morphogenesis. J Neurosci 20:6125-6134. (Pubitemid 30658406)
104. Pitteloud N, Acierno Jr JS, Meysing A, Eliseenkova AV, Ma J, Ibrahimi OA, Metzger DL, Hayes FJ, Dwyer AA, Hughes VA, Yialamas M, Hall JE, Grant E, Mohammadi M, Crowley Jr WF. 2006. Mutations in fibroblast growth factor receptor 1 cause both Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism. Proc Natl Acad Sci USA 103:6281-6286.
105. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, Stenroos ES, Chandrasekharappa S, Athanassiadou A, Papapetropoulos T, Johnson WG, Lazzarini AM, Duvoisin RC, Di Iorio G, Golbe LI, Nussbaum RL. 1997. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276:2045-2047. (Pubitemid 27443610)
106. Raffioni S, Thomas D, Foehr ED, Thompson LM, Bradshaw RA. 1996. Comparison of the intracellular signaling responses by three chimeric fibroblast growth factor receptors in PC12 cells. Proc Natl Acad Sci USA 96:7178-7183. (Pubitemid 29299635)
107. Rapraeger AC, Krufka A, Olwin BB. 1991. Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science 252:1705-1708. (Pubitemid 21917092)
108. Represa J, León Y, Miner C, Giraldez F. 1991. The int-2 proto-oncogene is responsible for induction of the inner ear. Nature 353:561-563. (Pubitemid 21912555)
109. Rice R, Spencer-Dene B, Connor EC, Gritli-Linde A, McMahon AP, Dickson C, Thesleff I, Rice DP. 2004. Disruption of Fgf10/Fgfr2b-coordinated epithelialmesenchymal interactions causes cleft palate. J Clin Invest 113:1692-1700. (Pubitemid 39071661)
110. Riley BM, Mansilla MA, Ma J, Daack-Hirsch S, Maher BS, Raffensperger LM, Russo ET, Vieira AR, Dodé C, Mohammadi M, Marazita ML, Murray JC. 2007. Impaired FGF signaling contributes to cleft lip and palate. Proc Natl Acad Sci USA 104:4512-4517. (Pubitemid 47186256)
111. Rohmann E, Brunner HG, Kayserili H, Uyguner O, Nürnberg G, Lew ED, Dobbie A, Eswarakumar VP, Uzumcu A, Ulubil-Emeroglu M, Leroy JG, Li Y, Becker C, Lehnerdt K, Cremers CW, Yüksel-Apak M, Nürnberg P, Kubisch C, Schlessinger J, van Bokhoven H, Wollnik B. 2006. Mutations in different components of FGF signaling in LADD syndrome. Nat Genet 38:414-417.
112. Saito H, Kusano K, Kinosaki M, Ito H, Hirata M, Segawa H, Miyamoto K, Fukushima N. 2003. Human fibroblast growth factor-23 mutants suppress Na+-dependent phosphate co-transport activity and 1alpha,25-dihydroxyvitamin D3 production. J Biol Chem 278:2206-2211. (Pubitemid 36801287)
113. Sakamoto H, Mori M, Taira M, Yoshida T, Matsukawa S, Shimizu K, Sekiguchi M, Terada M, Sugimura T. 1986. Transforming gene from human stomach cancers and a noncancerous portion of stomach mucosa. Proc Natl Acad Sci USA 83:3997-4001.
114. Scearce-Levie K, Roberson ED, Gerstein H, Cholfin JA, Mandiyan VS, Shah NM, Rubenstein JL, Mucke L. 2008. Abnormal social behaviors in mice lacking Fgf17. Genes Brain Behav 7:344-354.
115. Schliekelman P, Slatkin M. 2002. Multiplex relative risk and estimation of the number of loci underlying an inherited disease. Am J Hum Genet 71:1369-1385. (Pubitemid 36015891)
116. Scott WK, Nance MA, Watts RL, Hubble JP, Koller WC, Lyons K, Pahwa R, Stern MB, Colcher A, Hiner BC, Jankovic J, Ondo WG, Allen Jr FH, Goetz CG, Small GW, Masterman D, Mastaglia F, Laing NG, Stajich JM, Slotterbeck B, Booze MW, Ribble RC, Rampersaud E, West SG, Gibson RA, Middleton LT, Roses AD, Haines JL, Scott BL, Vance JM, Pericak-Vance MA. 2001. Complete genomic screen in Parkinson disease: evidence for multiple genes. JAMA 286:2239-2244. (Pubitemid 33063145)
117. Sekine K, Ohuchi H, Fujiwara M, Yamasaki M, Yoshizawa T, Sato T, Yagishita N, Matsui D, Koga Y, Itoh N, Kato S. 1999. Fgf10 is essential for limb and lung formation. Nat Genet 21:138-141. (Pubitemid 29036301)
118. Shakkottai VG, Xiao M, Xu L, Wong M, Nerbonne JM, Ornitz DM, Yamada KA. 2009. FGF14 regulates the intrinsic excitability of cerebellar Purkinje neurons. Neurobiol Dis 33:81-88.
119. Shams I, Rohmann E, Eswarakumar VP, Lew ED, Yuzawa S, Wollnik B, Schlessinger J, Lax I. 2007. Lacrimo-auriculo-dento-digital syndrome is caused by reduced activity of the fibroblast growth factor 10 (FGF10)-FGF receptor 2 signaling pathway. Mol Cell Biol 27:6903-6912. (Pubitemid 47483639)
120. Shaoul E, Reich-Slotky R, Berman B, Ron D. 1995. Fibroblast growth factor receptors display both common and distinct signaling pathways. Oncogene 10:1553-1561.
121. Shimada T, Mizutani S, Muto T, Yoneya T, Hino R, Takeda S, Takeuchi Y, Fujita T, Fukumoto S, Yamashita T. 2001. Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc Natl Acad Sci USA 98:6500-6505. (Pubitemid 32488266)
122. Shimada T, Hasegawa H, Yamazaki Y, Muto T, Hino R, Takeuchi Y, Fujita T, Nakahara K, Fukumoto S, Yamashita T. 2004a. FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res 19:429-435. (Pubitemid 38787398)
123. Shimada T, Kakitani M, Yamazaki Y, Hasegawa H, Takeuchi Y, Fujita T, Fukumoto S, Tomizuka K, Yamashita T. 2004b. Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J Clin Invest 113:561-568. (Pubitemid 38542505)
124. Smallwood PM, Munoz-Sanjuan I, Tong P, Macke JP, Hendry SH, Gilbert DJ, Copeland NG, Jenkins NA, Nathans J. 1996. Fibroblast growth factor (FGF) homologous factors: new members of the FGF family implicated in nervous system development. Proc Natl Acad Sci USA 93:9850-9857. (Pubitemid 26296698)
125. Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M. 1997. Alpha-synuclein in Lewy bodies. Nature 388:839-840.
126. Steinberg Z, Myers C, Heim VM, Lathrop CA, Rebustini IT, Stewart JS, Larsen M, Hoffman MP. 2005. FGFR2b signaling regulates ex vivo submandibular gland epithelial cell proliferation and branching morphogenesis. Development 132:1223-1234. (Pubitemid 40528783)
127. Strewler GJ. 2001. FGF23, hypophosphatemia, and rickets: has phosphatonin been found? Proc Natl Acad Sci USA 98:5945-5946.
128. Tekin M, His-mi BO, Fitoz S, Ozdaǧ H, Cengiz FB, Sirmaci A, Aslan I, Inceoǧlu B, Yüksel-Konuk EB, Yilmaz ST, Yasun O, Akar N. 2007. Homozygous mutations in fibroblast growth factor 3 are associated with a new form of syndromic deafness characterized by inner ear agenesis, microtia, and microdontia. Am J Hum Genet 80:338-344. (Pubitemid 46175681)
129. Tekin M, Oztürkmen Akay H, Fitoz S, Birnbaum S, Cengiz FB, Sennaroǧlu L, Incesulu A, Yüksel Konuk EB, Hasanefendioǧlu Bayrak A, Sentürk S, Cebeci I, Utine GE, Tunc- bilek E, Nance WE, Duman D. 2008. Homozygous FGF3 mutations result in congenital deafness with inner ear agenesis, microtia, and microdontia. Clin Genet 73:554-565.
130. Ten Hagen KG, Fritz TA, Tabak LA. 2003. All in the family: the UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases. Glycobiology 13:1R-16R.
131. Topaz O, Shurman DL, Bergman R, Indelman M, Ratajczak P, Mizrachi M, Khamaysi Z, Behar D, Petronius D, Friedman V, Zelikovic I, Raimer S, Metzker A,
132. Topaz O, Bergman R, Mandel U, Maor G, Goldberg R, Richard G, Sprecher E. 2005. Absence of intraepidermal glycosyltransferase ppGalNac-T3 expression in familial tumoral calcinosis. Am J Dermatopathol 27:211-215. (Pubitemid 40726774)
133. Umbhauer M, Penzo-Méndez A, Clavilier L, Boucaut J, Riou J. 2000. Signaling specificities of fibroblast growth factor receptors in early Xenopus embryo. J Cell Sci 113:2865-2875.
134. Urakawa I, Yamazaki Y, Shimada T, Iijima K, Hasegawa H, Okawa K, Fujita T, Fukumoto S, Yamashita T. 2006. Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature 444:770-774. (Pubitemid 44949607)
135. van der Walt JM, Noureddine MA, Kittappa R, Hauser MA, Scott WK, McKay R, Zhang F, Stajich JM, Fujiwara K, Scott BL, Pericak-Vance MA, Vance JM, Martin ER. 2004. Fibroblast growth factor 20 polymorphisms and haplotypes strongly influence risk of Parkinson disease. Am J Hum Genet 74:1121-1127. (Pubitemid 38669311)
136. van Swieten JC, Brusse E, de Graaf BM, Krieger E, van de Graaf R, de Koning I, Maat-Kievit A, Leegwater P, Dooijes D, Oostra BA, Heutink P. 2003. A mutation in the fibroblast growth factor 14 gene is associated with autosomal dominant cerebellar ataxia. Am J Hum Genet 72:191-199. (Pubitemid 36056856)
137. Vendrell V, Carnicero E, Giraldez F, Alonso MT, Schimmang T. 2000. Induction of inner ear fate by FGF3. Development 127:2011-2019. (Pubitemid 30386666)
138. Vincentz JW, McWhirter JR, Murre C, Baldini A, Furuta Y. 2005. Fgf15 is required for proper morphogenesis of the mouse cardiac outflow tract. Genesis 41:192-201. (Pubitemid 40656691)
139. Wang JK, Gao G, Goldfarb M. 1994. Fibroblast growth factor receptors have different signaling and mitogenic potentials. Mol Cell Biol 14:181-188. (Pubitemid 24013080)
140. Wang Q, Bardgett ME, Wong M, Wozniak DF, Lou J, McNeil BD, Chen C, Nardi A, Reid DC, Yamada K, Ornitz DM. 2002. Ataxia and paroxysmal dyskinesia in mice lacking axonally transported FGF14. Neuron 35:25-38. (Pubitemid 34804320)
141. WangG, van derWalt JM, Mayhew G, Li YJ, Züchner S, Scott WK, Martin ER, Vance JM. 2008. Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of α-synuclein. Am J Hum Genet 82:283-289.
142. White KE, Carn G, Lorenz-Depiereux B, Benet-Pagès A, Strom TM, Econs MJ. 2001. Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23. Kidney Int 60:2079-2086. (Pubitemid 33070451)
143. Wiedemann HR. 1997. Salivary gland disorders and heredity. Am J Med Genet 68:222-224.
144. Wilkie AO. 2005. Bad bones, absent smell, selfish testes: the pleiotropic consequences of human FGF receptor mutations. Cytokine Growth Factor Rev 16:187-203.
145. Wilkinson DG, Bhatt S, McMahon AP. 1989. Expression pattern of the FGF-related proto-oncogene int-2 suggests multiple roles in fetal development. Development 105:131-136. (Pubitemid 19046657)
146. Wittmack EK, Rush AM, Craner MJ, Goldfarb M, Waxman SG, Dib-Hajj SD. 2004. Fibroblast growth factor homologous factor 2B: association with Nav1.6 and selective colocalization at nodes of Ranvier of dorsal root axons. J Neurosci 24:6765-6775. (Pubitemid 38993898)
147. Wozniak DF, Xiao M, Xu L, Yamada KA, Ornitz DM. 2007. Impaired spatial learning and defective theta burst induced LTP in mice lacking fibroblast growth factor 14. Neurobiol Dis 26:14-26. (Pubitemid 46436484)
148. Wright TJ, Mansour SL. 2003. FGF signaling in ear development and innervation. Curr Top Dev Biol 57:225-259.
149. Xiao M, Xu L, Laezza F, Yamada K, Feng S, Ornitz DM. 2007. Impaired hippocampal synaptic transmission and plasticity in mice lacking fibroblast growth factor 14. Mol Cell Neurosci 34:366-377. (Pubitemid 46330039)
150. Yan Lu S, Sheikh F, Sheppard PC, Fresnoza A, Duckworth ML, Detillieux KA, Cattini PA. 2008. FGF-16 is required for embryonic heart development. Biochem Biophys Res Commun 373:270-274.
151. Yayon A, Klagsbrun M, Esko JD, Leder P, Ornitz DM. 1991. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 64:841-848. (Pubitemid 121001170)
152. Yoshiko Y, Wang H, Minamizaki T, Ijuin C, Yamamoto R, Suemune S, Kozai K, Tanne K, Aubin JE, Maeda N. 2007. Mineralized tissue cells are a principal source of FGF23. Bone 40:1565-1573. (Pubitemid 46756409)
153. Zhan X, Bates B, Hu XG, Goldfarb M. 1988. The human FGF-5 oncogene encodes a novel protein related to fibroblast growth factors. Mol Cell Biol 8:3487-3495. (Pubitemid 18192528)
154. Zhang X, Ibrahimi OA, Olsen SK, Umemori H, Mohammadi M, Ornitz DM. 2006. Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family. J Biol Chem 281:15694-15700. (Pubitemid 43848456)
155. Zhou M, Sutliff RL, Paul RJ, Lorenz JN, Hoying JB, Haudenschild CC, Yin M, Coffin JD, Kong L, Kranias EG, Luo W, Boivin GP, Duffy JJ, Pawlowski SA, Doetschman T. 1998. Fibroblast growth factor 2 control of vascular tone. Nat Med 4:201-207. (Pubitemid 28137375)